The use of Brazilian propolis for discovery and development of novel anti-inflammatory drugs

European Journal of Medicinal Chemistry

Volumn 153, Issue , 2018, Pages 49-55

  Franchin, Marcelo ^a   Freires, Irlan Almeida ^b   Lazarini, Josy Goldoni ^a   Nani, Bruno Dias ^a   da Cunha, Marcos Guilherme ^a   Colón, David Fernando ^c   de Alencar, Severino Matias ^c   Rosalen, Pedro Luiz ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti Inflammatory; Apis mellifera bee; Leukocyte; Neutrophils; Propolis

Indexed keywords

ANTIINFLAMMATORY AGENT; PROPOLIS;

ANTIINFLAMMATORY ACTIVITY; APIS MELLIFERA; BRAZIL; DRUG CLASSIFICATION; DRUG ISOLATION; INFLAMMATION; LEUKOCYTE; NONHUMAN; REVIEW; ANIMAL; BEE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECT; HUMAN; IMMUNOLOGY; MOLECULARLY TARGETED THERAPY; NEUTROPHIL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BEES; BRAZIL; DRUG DISCOVERY; HUMANS; INFLAMMATION; LEUKOCYTES; MOLECULAR TARGETED THERAPY; NEUTROPHILS; PROPOLIS;

EID: 85025823654     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2017.06.050     Document Type: Review

References (65)

1. Griffith, J.E., Luster, A.D., Targeting cells in motion: migrating toward improved therapies. Eur. J. Immunol. 43 (2013), 1430–1435.
2. Peres, R.S., Menezes, G.B., Teixeira, M.M., Cunha, F.Q., Pharmacological opportunities to control inflammatory diseases through inhibition of the leukocyte recruitment., 112, 2016, 37–48.
3. Wright, H.L., Moots, R.J., Bucknall, R.C., Edwards, S.W., Neutrophil function in inflammation and inflammatory diseases. Rheumatol. Oxf. 49 (2010), 1618–1631.
4. Kolaczkowska, E., Kubes, P., Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13 (2013), 159–175.
5. Ulbrich, H., Eriksson, E.E., Lindbom, L., Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol. Sci. 24 (2003), 640–647.
6. Mackay, C.R., Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat. Immunol. 9 (2008), 988–998.
7. Mitroulis, I., Alexaki, V.I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., Chavakis, T., Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol. Ther. 147 (2015), 123–135.
8. Newman, D.J., Cragg, G.M., Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79 (2016), 629–661.
9. Calixto, J.B., Biopirataria: a Biodiversidade na Mira da Indústria Farmacêutica. Ciênc. Hoj. 28 (2000), 36–43.
10. Ferro, A.F.P., Bonacelli, M.B.B., Assad, A.L.D., Oportunidades biotecnológicas e estratégias concorrenciais de gestão ambiental: o uso sustentável da biodiversidade brasileira. Gestão produção 13 (2006), 489–501.
11. Freires, I.A., Alencar, S.M., Rosalen, P.L., A pharmacological perspective on the use of Brazilian red propolis and its isolated compounds against human diseases. Eur. J. Med. Chem. 110 (2016), 267–279.
12. Franchin, M., Rosalen, P.L., da Cunha, M.G., Silva, R.L., Colón, D.F., Bassi, G.S., de Alencar, S.M., Ikegaki, M., Alves-Filho, J.C., Cunha, F.Q., Beutler, J.A., Cunha, T.M., Cinnamoyloxy-mammeisin isolated from geopropolis attenuates inflammatory process by inhibiting cytokine production: involvement of MAPK, AP-1, and NF-κB. J. Nat. Prod. 79 (2016), 1828–1833.
13. da Cunha, M.G., Franchin, M., Paula-Eduardo, L.F., Freires, I.A., Beutler, J.A., Alencar, S.M., Ikegaki, M., Tabchoury, C.P.M., Cunha, T.M., Rosalen, P.L., Anti-inflammatory and anti-biofilm properties of ent-nemorosone from Brazilian geopropolis. J. Funct. Foods 26 (2016), 27–35.
14. Paulino, N., Teixeira, C., Martins, R., Scremin, A., Dirsch, V.M., Vollmar, A.M., Abreu, S.R., de Castro, S.L., Marcucci, M.C., Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis. Planta Med. 72 (2006), 899–906.
15. Paulino, N., Abreu, S.R.L., Uto, Y., Koyama, D., Nagasawa, H., Hori, H., Dirsch, V.M., Vollmar, A.M., Scremin, A., Bretz, W.A., Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. Eur. J. Pharmacol., 2008, 296–301.
16. Bueno-Silva, B., Franchin, M., Alves, C.F., Denny, C., Colón, D.F., Cunha, T.M., Alencar, S.M., Napimoga, M.H., Rosalen, P.L., Main pathways of action of Brazilian red propolis on the modulation of neutrophils migration in the inflammatory process. Phytomedicine 23 (2016), 1583–1590.
17. Franchin, M., Cólon, D.F., Castanheira, F.V.S., da Cunha, M.G., Bueno-Silva, B., Alencar, S.M., Cunha, T.M., Rosalen, P.L., Vestitol isolated from Brazilian red propolis inhibits neutrophils migration in the inflammatory process: elucidation of the mechanism of action. J. Nat. Prod. 79 (2016), 954–960.
18. Franchin, M., Cólon, D.F., da Cunha, M.G., Castanheira, F.V.S., Saraiva, A.L.L., Bueno-Silva, B., Alencar, S.M., Cunha, T.M., Rosalen, P.L., Neovestitol, an isoflavonoid isolated from Brazilian red propolis, reduces acute and chronic inflammation: involvement of nitric oxide and IL-6. Sci. Rep., 6, 2016, 36401.
19. Tiveron, A.P., Rosalen, P.L., Franchin, M., Lacerda, R.C., Bueno-Silva, B., Denny, c., Ikegaki, M., Alencar, S.M., Chemical characterization and antioxidant, antimicrobial, and anti-inflammatory activities of South Brazilian organic propolis., 11, 2016, e0165588.
20. Koo, H., Hayacibara, M.F., Schobel, B.D., Cury, J.A., Rosalen, P.L., Park, Y.K., Vacca-Smith, A.M., Bowen, W.H., Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol. J. Antimicrob. Chemother. 52 (2003), 782–789.
21. Alencar, S.M., Oldoni, T.L., Castro, M.L., Cabral, I.S., Costa-Neto, C.M., Cury, J.A., Rosalen, P.L., Ikegaki, M., Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J. Ethnopharmacol. 113 (2007), 278–283.
22. Kummer, C.L., Coelho, T.C.R.B., Anti-inflamatórios Não Esteróides Inibidores da Ciclooxigenase-2 (COX-2): aspectos Atuais. Rev. Bras. Anestesiol. 52 (2002), 498–512.
23. Laveti, D., Kumar, M., Hemalatha, R., Sistla, R., Naidu, V.G., Talla, V., Verma, V., Kaur, N., Nagpal, R., Anti-inflammatory treatments for chronic diseases: a review. Inflamm. Allergy-Drug Targets 12 (2013), 349–361.
24. Kreuger, J., Phillipson, M., Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. Nat. Rev. Drug Discov. 15 (2016), 125–142.
25. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y., Zychlinsky, A., Neutrophil extracellular traps kill bacteria. Science 303 (2004), 1532–1535.
26. Kruger, P., Saffarzadeh, M., Weber, A.N., Rieber, N., Radsak, M., von Bernuth, H., Benarafa, C., Roos, D., Skokowa, J., Hartl, D., Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog., 11, 2015, e1004651.
27. Sadik, D.C., Luster, A.D.J., Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation. Leukoc. Biol. 91 (2012), 207–215.
28. Sallusto, F., Baggiolini, M., Chemokines and leukocyte traffic. Nat. Immunol. 9 (2008), 949–952.
29. Wynn, T.A., Chawla, A., Pollard, J.W., Macrophage biology in development, homeostasis and disease. Nature 496 (2013), 445–455.
30. Arthur, J.S., Ley, S.C., Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13 (2013), 679–692.
31. Karin, M.J., The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270 (1995), 16483–16486.
32. Reber, L., Vermeulen, L., Haegeman, G., Frossard, N., Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS One, 4, 2009, e4393.
33. Li, Q., Verma, I.M., NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2 (2002), 725–734.
34. Ley, K., Laudanna, C., Cybulsky, M.I., Nourshargh, S., Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 (2007), 678–689.
35. Nourshargh, S., Alon, R., Leukocyte migration into inflamed tissues. Immunity 41 (2014), 694–707.
36. Tecchio, C., Micheletti, A., Cassatella, M.A., Neutrophil-derived cytokines: facts beyond expression. Front. Immunol., 5, 2014, 508.
37. Van Dyke, T.E., Serhan, C.N., Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82 (2003), 82–90.
38. Braunersreuther, V., Mach, F., Leukocyte recruitment in atherosclerosis: potential targets for therapeutic approaches?. Cell Mol. Life Sci. 63 (2006), 2079–2088.
39. Gernez, Y., Tirouvanziam, R., Chanez, P., Neutrophils in chronic inflammatory airway diseases: can we target them and how?. Eur. Respir. J. 35 (2010), 467–469.
40. Caielli, S., Banchereau, J., Pascual, V., Neutrophils come of age in chronic inflammation. Curr. Opin. Immunol. 24 (2012), 671–677.
41. Silva, B.B., Rosalen, P.L., Cury, J.A., Ikegaki, M., Souza, V.C., Esteves, A., Alencar, S.M., Chemical composition and botanical origin of red propolis, a new type of Brazilian propolis. Evid. Based Complement. Altern. Med. 5 (2008), 313–316.
42. Sheppard, W.S., Rinderer, T.E., Mazzoli, J.A., Stelzer, J.A., Shimanuki, H., Gene flow between african- and european-derived honey bee populations on Argentina. Nature 349 (1991), 782–784.
43. Bankova, V., Chemical diversity of propolis and the problem of standardization. J. Ethnopharmacol. 100 (2005), 114–117.
44. Silva-Carvalho, R., Baltazar, F., Almeida-Aguiar, C., Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evid. Based Complement. Altern. Med., 206439, 2015.
45. Ghisalberti, E.L., Propolis: a review. Bee World 60 (1979), 59–84.
46. Park, Y.K., Alencar, S.M., Aguiar, C.L., Botanical origin and chemical composition of Brazilian propolis. J. Agric. Food Chem. 50 (2002), 2502–2506.
47. Trusheva, B., Popova, M., Bankova, V., Simova, S., Marcucci, M.C., Miorin, P.L., Pasin, F.R., Tsvetkova, I., Bioactive constituents of brazilian red propolis. Evid. Based. Complement. Altern. Med. 3 (2006), 249–254.
48. Park, Y.K., Ikegaki, M., Alencar, S.M., Classification of Brazilian propolis by physicochemical method and biological activity. Mensagem Doce 58 (2000), 2–7.
49. Ito, J., Chang, F.R., Wang, H.K., Park, Y.K., Ikegaki, M., Kilgore, N., Lee, K.H., Anti-AIDS agents. 48. (1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. J. Nat. Prod. 64 (2001), 1278–1281.
50. Alencar, S.M., Estudo fitoquímico da origem botânica da própolis e avaliação da composição química de mel de Apis melífera africanizada de diferentes regiões do Brasil. 2002, Universidade Estadual de Campinas, Campinas, 116 15.02.2002. Tese (Doutorado) http://www.bibliotecadigital.unicamp.br/document/?code=000222747&fd=y.
51. Castro, M.L., Nascimento, A.M., Ikegaki, M., Costa-Neto, C.M., Alencar, S.M., Rosalen, P.L., Dentification of a bioactive compound isolated from Brazilian propolis type 6. Bioorg. Med. Chem. 17 (2009), 5332–5335.
52. Oldoni, T.L.C., Cabral, I.S.R., d'Arce, M.A.B.R., Rosalen, P.L., Ikegaki, M., Nascimento, A.M., lencar, S.M., Isolation and analysis of bioactive isoflavonoids and chalcone from a new type of Brazilian propolis. Sep. Purif. Technol. 77 (2011), 208–213.
53. Alves, C.F., Alves, V.B.F., Assis, I.P., Clemente-Napimoga, J.T., Uber-Bucek, E., Dal-Secco, D., Cunha, F.Q., Rehder, V.L.G., Napimoga, M., Anti-inflammatory activity and possible mechanism of extract from Mikania laevigata in carrageenan-induced peritonitis. J. Pharm. Pharmacol. 61 (2009), 1097–1104.
54. Denny, C., Lazarini, J.G., Franchin, M., Melo, P.S., Pereira, G.E., Massarioli, A.P., Moreno, I.A.M., Paschoal, J.A.R., Alencar, S.M., Rosalen, P.L., Bioprospection of Petit Verdot grape pomace as a source of anti-inflammatory compounds. J. Funct. Foods 8 (2014), 292–300.
55. Benso, B., Franchin, M., Massarioli, A.P., Paschoal, J.A., Alencar, S.M., Franco, G.C., Rosalen, P.L., Anti-inflammatory, anti-osteoclastogenic and antioxidant effects of malva sylvestris extract and fractions: in vitro and in vivo studies. PLoS One, 11, 2016, e0162728.
56. Zhang, X., Wang, G., Gurley, E.C., Zhou, H., Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLos One 9 (2014), 5–9.
57. Cardenas, H., Arango, D., Nicholas, C., Duarte, S., Nuovo, G.L., He, W., Voss, O.H., Gonzalez-Mejia, M.E., Guttridge, D.C., Grotewold, E., Doseff, A.I., Dietary apigenin exerts immune-regulatory activity in vivo by reducing NF-κB activity, halting leukocyte infiltration and restoring normal metabolic function. Int. J. Mol. Sci., 17, 2016, 323.
58. Jung, Y.C., Kim, M.E., Yoon, J.H., Park, P.R., Youn, H.Y., Lee, H.W., Lee, J.S., Anti-inflammatory effects of galangin on lipopolysaccharide-activated macrophages via ERK and NF-kB pathway regulation. Immunopharmacol. Immunotoxicol. 36 (2014), 426–432.
59. Santos, E.O., Kabeya, L.M., Figueiredo-Rinhel, A.S., Marchi, L.F., Andrade, M.F., Piatesi, F., Paoliello-Paschoalato, A.B., Azzolini, A.E., Lucisano-Valim, Y.M., Flavonols modulate the effector functions of healthy individuals’ immune complex-stimulated neutrophils: a therapeutic perspective for rheumatoid arthritis. Int. Immunopharmacol. 1 (2014), 102–111.
60. Soromou, L.W., Chu, X., Jiang, L., Wei, M., Huo, M., Chen, N., Guan, S., Yang, X., Chen, C., Feng, H., Deng, X., In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. Int. Immunopharmacol. 1 (2012), 66–74.
61. Cavendish, R.L., Santos, J.S., Neto, R.B., Paixão, A.O., Oliveira, J.V., Araujo, E.D., Silva, A.A.B., Thomazzi, S.M., Cardoso, J.C., Gomes, M.Z., Antinociceptive and anti-inflammatory effects of Brazilian red propolis extract and formononetin in rodents. J. Ethnopharmacol. 173 (2015), 127–133.
62. Wang, Y., Zhu, Y., Gao, L., Yin, H., Xie, Z., Wang, D., Zhu, Z., Han, X., Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells. Molecules 17 (2012), 10052–10064.
63. Bueno-Silva, B., Alencar, S.M., Koo, H., Ikegaki, M., Silva, G.V.J., Napimoga, M., Rosalen, P.L., Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from brazilian red propolis. J. Agric. Food Chem., 61(19), 2013.
64. Kumar, S., Sharma, A., Madan, B., Singhal, V., Ghosh, B., Isoliquiritigenin inhibits IkB kinase activity and ROS generation to block TNF-a induced expression of cell adhesion molecules on human endothelial cells. Biochem. Pharmacol. 73 (2007), 1602–1612.
65. Feng, G., Sun, B., Lia, T., Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Int. Immunopharmacol. 26 (2015), 392–400.